Pyrimidiner och derivat
Filtrerade sökresultat
PROTAC BET Degrader-1, MedChemExpress
MedChemExpress PROTAC BET Degrader-1 is a PROTAC connected by ligands for Cereblon and BET, decreasing BRD2, BRD3, and BRD4 protein levels at low concentration.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C44H45N11O9 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 871.9 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 50 mg/mL (57.35 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Yellow |
| CAS | 2093386-22-0 |
| LEDER | CCN1C(NC2=C3C4=CC(OC)=C(C(C(C)=NO5)=C5C)C=C4NC3=NC(C(NCCCCNC(COC6=C(C(N7C(CCC8=O)C(N8)=O)=O)C(C7=O)=CC=C6)=O)=O)=N2)=CC(C9CC9)=N1 |
| Molekylvikt (g/mol) | 871.9 |
| Kemiskt namn eller material | PROTAC BET Degrader-1 |
| Procent renhet | 98.01% |
| För användning med (applikation) | Cancer-programmed cell death |
AF64394, MedChemExpress
MedChemExpress AF64394 is a GPR3 inverse agonist, with a pIC50 of 7.3.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C21H20ClN5O |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 393.87 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H302 |
| Löslighetsinformation | DMSO : ≥ 125 mg/mL (317.36 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 1637300-25-4 |
| LEDER | ClC1=CC(OC(C)C)=C(CNC2=CC(C3=CC=CC=C3)=NC4=NC=NN42)C=C1 |
| Molekylvikt (g/mol) | 393.87 |
| Kemiskt namn eller material | AF64394 |
| Procent renhet | 98.02% |
LDC000067, MedChemExpress
MedChemExpress LDC000067 is a highly specific CDK9 inhibitor with an IC50 value of 44±10 nM in vitro.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C18H18N4O3S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 370.43 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 47 mg/mL (126.88 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 1073485-20-7 |
| LEDER | O=S(CC1=CC=CC(NC2=NC=NC(C3=CC=CC=C3OC)=C2)=C1)(N)=O |
| Molekylvikt (g/mol) | 370.43 |
| Synonym | LDC067 |
| Kemiskt namn eller material | LDC000067 |
| Procent renhet | 98.58% |
| För användning med (applikation) | Cancer-Kinase/protease |
BMS-833923, MedChemExpress
MedChemExpress BMS-833923 (XL-139) is an orally bioavailable small-molecule inhibitor of Smoothened with potential antineoplastic activity; inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner with an IC50 of 21 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C30H27N5O |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 473.57 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H302 |
| Löslighetsinformation | DMSO : 50 mg/mL (105.58 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Yellow |
| CAS | 1059734-66-5 |
| LEDER | O=C(NC1=CC(CNC)=CC=C1C)C2=CC=C(NC3=NC(C4=CC=CC=C4)=C5C=CC=CC5=N3)C=C2 |
| Molekylvikt (g/mol) | 473.57 |
| Synonym | XL-139 |
| Kemiskt namn eller material | BMS-833923 |
| Procent renhet | 98.21% |
| För användning med (applikation) | Cancer-programmed cell death |
ABT-046, MedChemExpress
MedChemExpress ABT-046 is a potent, selective, and orally efficacious acyl CoA:diacylglycerol acyltransferase 1 (DGAT-1) inhibitor (IC50= 8 nM).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C20H22N4O2 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 350.41 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 66.67 mg/mL (190.26 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 1031336-60-3 |
| LEDER | NC1=C(C2=CC=C([C@H]3CC[C@H](CC(O)=O)CC3)C=C2)C=NC4=CC=NN41 |
| Molekylvikt (g/mol) | 350.41 |
| Kemiskt namn eller material | ABT-046 |
| Procent renhet | 98.13% |
| För användning med (applikation) | Neuroscience-Neuromodulation |
HDACs/mTOR Inhibitor 1, MedChemExpress
MedChemExpress HDACs/mTOR Inhibitor 1 is a dual Histone Deacetylases (HDACs) and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies, with IC50s of 0.19 nM, 1.8 nM, 1.2 nM and >500 nM for HDAC1, HDAC6, mTOR and PI3Kα, respectively. HDACs/mTOR Inhibitor 1 stimulates cell cycle arrest in G0/G1 phase and induce tumor cell apoptosis with low toxicity in vivo.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C28H38N8O5 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 566.65 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 32.5 mg/mL (57.35 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 2271413-06-8 |
| LEDER | O=C(NO)CCCCCCN1C2=NC(C3=CC=C(NC(N4C[C@@H](C)OCC4)=O)C=C3)=NC(N5CCOCC5)=C2C=N1 |
| Molekylvikt (g/mol) | 566.65 |
| Kemiskt namn eller material | HDACs/mTOR Inhibitor 1 |
| Procent renhet | 98.21% |
| För användning med (applikation) | Neuroscience-Neurodegeneration |
BML-284, MedChemExpress
MedChemExpress BML-284 is a potent and cell-permeable Wnt signaling activator. BML-284 induces TCF-dependent transcriptional activity with an EC50 of 700 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C19H18N4O3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 350.37 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 100 mg/mL (285.41 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Powder |
| Kvalitet | Research |
| Färg | White |
| CAS | 853220-52-7 |
| LEDER | NC1=NC(C2=CC=CC(OC)=C2)=CC(NCC3=CC=C(OCO4)C4=C3)=N1 |
| Molekylvikt (g/mol) | 350.37 |
| Kemiskt namn eller material | BML-284 |
| Procent renhet | 97.48% |
| För användning med (applikation) | Cancer-programmed cell death |
CZ415, MedChemExpress
MedChemExpress CZ415 is a potent and highly selective mTOR inhibitor with a pIC50 of 8.07. CZ415 inhibits mTORC1 and mTORC2 protein complex.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C22H29N5O4S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 459.56 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 100 mg/mL (217.60 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 1429639-50-8 |
| LEDER | O=C(NCC)NC(C=C1)=CC=C1C2=NC3=C(CS(C3(C)C)(=O)=O)C(N4[C@@H](C)COCC4)=N2 |
| Molekylvikt (g/mol) | 459.56 |
| Kemiskt namn eller material | CZ415 |
| Procent renhet | 98.74% |
| För användning med (applikation) | Cancer-Kinase/protease |
LDN-212854, MedChemExpress
MedChemExpress LDN-212854 is a bone morphogenetic protein (BMP) inhibitor that potently inhibits ALK2 (IC50: 1.3 nM). LDN-212854 also inhibits ALK1 (IC50: 2.40 nM). LDN-212854 can be used in the research of fibrodysplasia ossificans progressive and cancers, such as hepatocellular carcinoma (HCC).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C25H22N6 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 406.48 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H301 |
| Löslighetsinformation | DMSO : ≥ 30 mg/mL (73.80 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Light Yellow |
| CAS | 1432597-26-6 |
| LEDER | C12=C(C3=C4N=CC(C5=CC=C(N6CCNCC6)C=C5)=CN4N=C3)C=CC=C1N=CC=C2 |
| Molekylvikt (g/mol) | 406.48 |
| Kemiskt namn eller material | LDN-212854 |
| Procent renhet | 99.65% |
| För användning med (applikation) | Cancer-Kinase/protease |
Filorexant, MedChemExpress
MedChemExpress Filorexant (MK-6096) is an orally bioavailable potent and selective reversible antagonist of OX1 and OX2 receptor(<3 nM in binding).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C24H25FN4O2 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 420.48 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 100 mg/mL (237.82 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Powder |
| Kvalitet | Research |
| Färg | Light Brown |
| CAS | 1088991-73-4 |
| LEDER | CC1=CC(C(N2C[C@H](COC3=CC=C(F)C=N3)CC[C@H]2C)=O)=C(C4=NC=CC=N4)C=C1 |
| Molekylvikt (g/mol) | 420.48 |
| Synonym | MK-6096 |
| Kemiskt namn eller material | Filorexant |
| Procent renhet | 98.95% |
| För användning med (applikation) | Neuroscience-Neuromodulation |
Citarinostat, MedChemExpress
MedChemExpress Citarinostat (ACY241) is a second generation potent, orally active and high-selective HDAC6 inhibitor with an IC50 of 2.6 nM (IC50s of 35 nM, 45 nM, 46 nM and 137 nM for HDAC1, HDAC2, HDAC3 and HDAC8, respectively). Citarinostat has anticancer effects.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C24H26ClN5O3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 467.95 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 30 mg/mL (64.11 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 1316215-12-9 |
| LEDER | O=C(C1=CN=C(N(C2=CC=CC=C2Cl)C3=CC=CC=C3)N=C1)NCCCCCCC(NO)=O |
| Molekylvikt (g/mol) | 467.95 |
| Synonym | ACY241 |
| Kemiskt namn eller material | Citarinostat |
| Procent renhet | 95.0% |
| För användning med (applikation) | Cancer-programmed cell death |
2'-Deoxyinosine, MedChemExpress
MedChemExpress 2’-deoxyadenosine inhibits the growth of human colon-carcinoma cell lines and is found to be associated with purine nucleoside phosphorylase (PNP) deficiency.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
MK-8617, MedChemExpress
MedChemExpress MK-8617 is an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) with an IC50 of 1 nM for PHD2.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C24H21N5O4 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 443.45 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 6 mg/mL (13.53 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 1187990-87-9 |
| LEDER | O=C(C1=CN=C(C2=NN=CC=C2)N=C1O)NC(C3=CC=C(OC)C=C3)C4=CC=C(OC)C=C4 |
| Molekylvikt (g/mol) | 443.45 |
| Kemiskt namn eller material | MK-8617 |
| Procent renhet | 98.02% |
| För användning med (applikation) | COVID-19-immunoregulation |
ALLO-2, MedChemExpress
MedChemExpress ALLO-2 is a potent drug-resistant Smoothened (Smo) mutant antagonist that inhibits Smo agonist Hh-Ag1.5-induced luciferase expression in TM3-Gli-Luc cells with IC50 of 6 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C18H12F3N5O |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 371.32 |
| Hållbarhet | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H302∣H315∣H319∣H335 |
| Löslighetsinformation | DMSO : 125 mg/mL (336.64 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Yellow |
| CAS | 1357350-60-7 |
| LEDER | FC(F)(OC1=CC=C(C=C1)C2=NC(NC3=CC4=C(C=C3)NN=C4)=NC=C2)F |
| Molekylvikt (g/mol) | 371.32 |
| Kemiskt namn eller material | ALLO-2 |
| Procent renhet | 99.58% |
| För användning med (applikation) | Cancer-programmed cell death |
EPZ015666, MedChemExpress
MedChemExpress EPZ015666 (GSK3235025) is an orally available inhibitor of PRMT5 with an IC50 of 22 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C20H25N5O3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 383.44 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 100 mg/mL (260.80 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 1616391-65-1 |
| LEDER | O=C(NC[C@H](O)CN1CCC(C=CC=C2)=C2C1)C3=CC(NC4COC4)=NC=N3 |
| Molekylvikt (g/mol) | 383.44 |
| Synonym | GSK3235025 |
| Kemiskt namn eller material | EPZ015666 |
| Procent renhet | 98.96% |
| För användning med (applikation) | Cancer-programmed cell death |